Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 16.48
+0.09 (0.55%)
Jun 18, 2026, 3:04 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 9.81 billion as of June 18, 2026. Its market cap has decreased by -0.54% in one year.
Market Cap
9.81B
Enterprise Value
7.06B
Revenue
1.20B
Ranking
n/a
PE Ratio
52.30
Stock Price
16.48
Market Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 9.81B, a decrease of -65.13%. That is a compound annual growth rate of -21.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 9.81B | -11.54% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Cheezheng Tibetan Medicine | 11.55B |
| Pacific Shuanglin Bio-pharmacy | 11.16B |
| Inner Mongolia Furui Medical Science | 11.12B |
| Chengzhi | 11.00B |
| HitGen | 10.53B |
| Staidson (Beijing) BioPharmaceuticals | 9.82B |
| InventisBio | 9.57B |
| Jiangxi Fushine Pharmaceutical | 9.42B |